A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma

Name: A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma
License: Public Domain

Dana-Farber Cancer Institute

ClinicalTrials.gov · Datasets · License: Public Domain

mesothelioma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 230420
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.